Grimaud Brett A. (CIK 0001966698)

Latest company ownership

TBPH - Theravance Biopharma, Inc.
Role: SVP, GEN COUNSEL AND SECRETARY
Shares held
355,282
Last filed at
Nov 24, 2025
Confidence Score
40.6
2025Q4
Confidence Score History
2023Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 20, 2025 Nov 24, 2025 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 40.0 -19,024 -5.08% ✗ $340.5K
Aug 20, 2025 Aug 22, 2025 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -9,762 -2.54% ✗ $130.7K
May 20, 2025 May 22, 2025 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -9,743 -2.47% ✗ $92.1K
Feb 20, 2025 Feb 24, 2025 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -14,534 -4.36% ✗ $140.4K
Nov 20, 2024 Nov 22, 2024 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -9,268 -2.71% ✗ $92.4K
Aug 20, 2024 Aug 22, 2024 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -9,268 -2.63% ✗ $76.2K
May 20, 2024 May 22, 2024 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -9,268 -2.57% ✗ $84.3K
Feb 20, 2024 Feb 22, 2024 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -17,595 -6.32% ✗ $156.9K
Nov 20, 2023 Nov 22, 2023 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -7,363 -2.58% ✗ $76.4K
Aug 20, 2023 Aug 22, 2023 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -8,912 -3.03% ✗ $86.4K
May 20, 2023 May 23, 2023 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -11,469 -3.75% ✗ $128.6K
Feb 20, 2023 Feb 22, 2023 Theravance Biopharma, Inc. SVP, GEN COUNSEL AND SECRETARY Sell 42.5 -10,198 -4.25% ✗ $106.5K